Commentary: Intermittent Fasting and Akkermansia Muciniphila Potentiate the Antitumor Efficacy of FOLFOX in Colon Cancer

Front Pharmacol. 2022 Feb 11:13:843133. doi: 10.3389/fphar.2022.843133. eCollection 2022.

Authors

Junhong Su¹, Henri Braat¹, Auke Verhaar¹, Maikel Peppelenbosch¹

Affiliation

¹ Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center Rotterdam, Rotterdam, Netherlands.

No abstract available

Keywords: coloretal cancer; humans; intermittent fasting; the gut microbiome; translational medicine.

Publication types

Review